Literature DB >> 5498610

Pyelonephritis therapy in rats: random association with excreted urinary antibacterial activity.

S E Burrous, R Freedman, R E Chamberlain, R P Basson.   

Abstract

In vitro activities or excreted urinary activities of 56 generic and experimental drugs against two organisms commonly associated with human pyelonephritis, Escherichia coli and Proteus mirabilis, are not correlated with the in vivo activities of these compounds as measured by reduction of viable organisms in kidneys in experimental pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5498610      PMCID: PMC376997          DOI: 10.1128/am.20.4.598-599.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  3 in total

1.  ANTIMICROBIAL SUSCEPTIBILITY OF PATHOGENIC ORGANISMS ISOLATED FROM THE URINARY TRACT IN 1963.

Authors:  S S SCHNEIERSON
Journal:  N Y State J Med       Date:  1965-03-01

2.  The treatment of urinary tract infections with a new antibiotic-cephaloglycin.

Authors:  H M Trafton; H E Lind
Journal:  J Urol       Date:  1969-03       Impact factor: 7.450

3.  Rat pyelonephritis model suitable for primary or secondary screening.

Authors:  S E Burrous; J B Cawein
Journal:  Appl Microbiol       Date:  1969-09
  3 in total
  1 in total

1.  Effect of antibacterial therapy on renal lysozyme levels in rats developing bacterial pyelonephritis.

Authors:  W W Eudy; S E Burrous
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.